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Immunologic Unresponsiveness Induced by Topical Application of 
Hapten to PUV A-Treated Skin in Guinea Pigs 
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Pretreatment by topical a pplication of 8-methoxypsor-
alen and subsequ ent exposure to long-wave ultraviolet 
light (PUV A) on the induction s ite of contact sensitiza-
tion to dinitrochlorobenzene (DNCB) significantly dimin-
ished the challenge reactions in guinea pigs . A single 
treatment with PUV A in a small area was enough to 
exhibit s u ch an effect. Furthermore, the animals that 
had been first exposed to DNCB throu gh PUV A -treated 
skin failed to become sensitized to the s ubsequent sen-
sitization r egim en of the same hapte n even through pre-
viously untreated skin. The unresponsive n ess in these 
animals was hapten-specific, since the ir capacity to be-
come sensitize d to a n unrelated hapte n, oxas olon, was 
not impaired. The intraperitoneal administration of cy-
clophosphamide at a dose of 200 mg/kg shortly before 
contact sensitization reversed the unrespons iveness in 
tolerant animals. T hese findings suggest that tolerance 
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PUV A: psora len plus ultraviolet A 
T hy 1.2: T cell -specific antigen 
in these animals is a specific immunologic unresponsive-
ness mediate d by s uppressor cells. 
Photoimmunology is a new term which means t h e study of 
the effects of nonionizing radiation on normal and abnormal 
immune [unction [1,2]. In the past several years, great progress 
has been made in t his resear ch 'field mainly by experime n ts on 
photocal'cinogenesis a nd recently on contact h ypersensitivity . 
It was found that trinitrophe nyl-conjugated a n tigen-presen ting 
cells from ultraviolet (UV)-irradiated mice lost t h eil' capacity 
to sensit ize effectively and t hat the UV -irradiated a nimals 
immunized with such cells d eveloped an tigen-specific suppres-
sor T cells which [luther decreased hapten-specific hyp ersen-
sitivity responses [3]. More r ecently, Toews, B ergstr esser, a nd 
Streilein have s hown a direct correlation between t h e ability to 
induce con tact hypersensitivity reaction a nd th e number of 
ATPase-positive Langerha ns cells in th e epidermis [4]. In this 
experiment, t hey demonstrated th at a high degree of an t igen-
specific unl'esponsiveness was induced in m ice wh en a ntigen 
was applied thro ugh ta il skin or UV -exposed body wall s kin 
which was d efi cient in L a ngerhans cells . 
U ltraviolet B radia tion « 320 run) a lone a nd th e combination 
of psoralen a nd long-wave UV radiation (PUV A) have been 
used for the treatme nt of various skin disorders with similar 
therapeutic results. However, som e differences in t he effects on 
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experimental systems between these types of therapy have been 
reported. On lymphocytes, PUV A and UVB radiation appear 
to have different effects both in vitro and in vivo [5-8]. Kripke, 
Morison, and Parrish found that the effects of PUV A treatment 
differed from those of UVB radiation in t hat PUV A treatment 
did not alter the immunologic rejection ofUVB-induced tumors 
[9], while Roberts, Schmitt, and Daynes had observed contra-
dictory results [10]. However, the two studies used different 
UV A sources: Kripke et al used a Mylar filter to eliminate 
contaminating UVB radiation from the ligh t source, whereas 
Roberts et al employed the clinically accepted protocol of 
unfiltered UV A which also contains a significant amount of 
radiation in the UVB range. 
Previously, we demonstrated the similar effect of PUV A to 
that of UVB on Langerhans cells [11] and on the induction of 
contact hypersensitivity [12]. In the present study, we examined 
whether the same immunologic unresponsiveness of contact 
hypersensitivity can be induced by PUV A treatment as by 
UVB irradiation [4]. 
MATERIALS AND METHODS 
Anim.als 
Fem ale albino guinea pigs of t he Hartley strain, weighing 380-420 g, 
were used throughout t he experiments. 
Light Source 
A fluorescent black ligh t (Toshiba FL20S BLB, Toshiba M edical 
S upply, Tokyo) emi t ting rays 300-420 nm, ma inly long-wave UV rad ia -
t ion (UV A) peaking at 360 nm, was used, a nd 5 tubes were housed in 
a re fl ector uni t. The irradia nce of UVA (320-400 nm) which was 
measured by Toshiba UV 365 rad iometer (Toshiba M edical S upply) 
was 4.2 mW/c m2 at a distance of 15 cm. 
Sensitization of Contact Sensitivity 
The dorsal or nucha l area was dep ilated a nd immediate ly a fterward 
50 pl of 10% dinit rochlorobenzene (DNCB) in acetone was a pplied . 
E licitation of contact sensit ivity was per fo rmed 14 days later by t he 
application of 10 III of 0.1%, 0.05%, and 0.025% DNCB in acetone on the 
depilated flank. Sensit ization with oxasolon (4 -ethoxymethy lene-2-
pheny loxazol-5-one) was done by placing 50 III of 20% oxasolon in 
acetone, and elicitation tests were performed 14 days later by a pplica-
t ion of 10 III each of 1%, 0.5%, a nd 0.25% solut ion in t he same vehicle on 
the depilated fla nk. S kin reactions were read 24 hI' after t he challenge. 
The in tensity of t he r eactions was evaluated according to the fo llowing 
scale: no vis ib le cha nge = 0; sligh t or discr ete erythema = 1; moderate 
and conHuent e rythema = 2; in tense erythema a nd swe lling = 3. 
P UV A Treatm.ent 
Commercially ava ila ble 1% 8- methoxypsorale n solu t ion (Oxsorale n 
Lotion, T a isho Pharm. Co., Tokyo) was pa in ted to a 3 x 3 cm area of 
the depilated, midback of t he a nima ls . One hOllr later , t he guinea p igs 
were exposed to 7.6 J /c m 2 of UVA, which is eql!iva lent to 3-4 t imes 
minimal photo tox ic dose. 
RESULTS 
Inhibitory Effect of PUVA on Contact Sensitization 
Ten guinea pigs were treated with PUV A on the back and 3 
days later t he induction of contact sensitization to DNCB was 
attempted on the PUV A-treated site. T en control guinea pigs 
were sensitized to DNCB on the nontreated nuchal region. 
The sensitization rate to each DNCB concentration of elici-
tation and score (total scores/number of animals in each group) 
are summarized in Table 1. R eactions to 0.025% DNCB were 
detectable in none of th e 10 animals in which the sensitization 
was attempted at the PUVA-treated site (Group PUVA-1), 
while there were reactions in 4 of the control animals. Only 2 
and 9 guinea pigs in Group PUVA-1 reacted to 0.05% and 0.1% 
DNCB, respectively, although all control animals reacted to 
these concentrations. The score of reactions in Group PUVA-l 
(1.2) was significantly less than that in the control group (3.3). 
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TABLE 1. Inhibitol)' effect of PUVA on contact sensitization" 
No. of Sensitization rate" Group 
animals 'l~)'ealment ScoreI' 0.025% 0.05% 0.1 % 
Contro l 10 Sensit ization 4/ 10 10/ 10 10/ 10 3.3 
on non-
treated s ite 
PUVA-l 10 Sensitization 0110 2/10 9/ 10 1.2 
on PUVA-
treated s ite 
" T opical a pplication of 8-MOP 1 h1' prior to 7.6J / cmz exposme to 
UV A radiation was carried out in a 3 x 3 cm induction site 3 days 
before DNCB sensitization. 
I> Number of anima ls t hat reacted to each concen tration of DNCBI 
number of a nima ls tested. 
c Intens ity of r eactions was evaluated according to the fo llowing 
scale : - = 0; ± = 1; + = 2; ++ = 3. Score = total of scores to 3 
concentrations of DNCB per 1 animal. 
TABLE II. Induction of un.responsiven.ess" 
No. of Sensitization rate Group animals Treatment Score 0.025% 0.05% 0. 1% 
Control 10 Sensit ization 4/ 10 10/ 10 10/ 10 3.3 
on non-
tr ea ted si te 
PUVA-2 10 1st sensit iza- 0/ 10 4/ 10 10/ 10 1.6 
t ion on 
PUVA-
trea ted si te 
a nd 2nd on 
non treated 
site 
" Anima ls were sens it ized to DNCB on PUVA-t1'eated site a nd 11 
days later sens itized aga in on nontreated skin . 
TABLE III. Specificity of wl.responsiveness" 
ensitization rate to oxaso~ 
Groll p No. of Ion Score anilnals 
0.25% 0.5% 1% 
T oleran t animals to 10 5/ 10 10/ 10 10/ 10 4.0 
ONCB 
Sens it ive a nima ls to 10 6/ 10 JOl l 0 10/ 10 4.6 
DNCB 
" Anima ls t hat had achieved unrespons iveness to DNCB were sen-
s it ized to oxasolon. Animals that had been highly sensitized to DNCB 
were a lso sensitized a nd served as con tro l. 
Induction of Unresponsiveness 
T en guinea pigs (Group PUV A-2) were treated with PUV A 
on the back and, 3 days later, sensitized to DNCB on the 
PUV A-treated site. Eleven days later, the induction of contact 
sensit ization was attempted again on the nontreated nuchal 
area. 
T hese animals revealed elicitation reactions as low as those 
of the animals in which the sensitization was attempted only 
once at t he PUV A-treated site (Group PUV A-I) . None and 
only 4 guinea pigs reacted to 0.025% and 0.05% DNCB, respec-
tively. The score in this group was approximately half of that 
in the control group (Table II) . Therefore, the animals that 
were first exposed to DNCB thl'ough PUV A-treated skin re-
vealed suppressed challenge reactions to the subsequent sensi-
tization procedure even through non treated skin. 
Specificity of Unresponsiveness to DNCB 
The Group PUVA-1 animals that had achieved unrespon-
siveness to DNCB were sensitized to oxasolon at the nontr eated 
nuchal region 4 days after the challenge test of DNCB. The 
control group animals that had been highly sensit ized to DNCB 
were also sensitized to oxasolon. All guinea pigs responded well 
to oxasolon. There were no differences in the rate and severity 
of challenge reactions to oxasolon between these two groups 
(Table III) . 
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TABLE IV. Reversal of unresponsiveness by cyclophospham.ide" 
C roup No. of animals 'l 'l'ealmenl 0.025% 
Sensitizat.ion rat.e 
Score 
0.05% O. l% 
CY 
PUVA-1-CY 
10 
8 
C Y" and sensitization on non t reated site 
CY and sens it ization on PUVA-lreated 
s ite 
8/10 
6/ 8 
10/ 10 
8/8 
10/ 10 
8/8 
5.3 
4.6 
PUVA-2-CY 10 1s t sens it ization on P UVA-treated s ite, 
a nd t he n CY before 2nd sensit ization on 
nonlreated site 
10/10 10/10 10/ 10 5.6 
"Three days be fo re sens it izatio n cyclophosphamide was injected in trape ri tonea Liy al a dose of 200 mg/ i<g. 
" CY represents intraperitoneal injection of cyclophospham ide. 
Pretreatment wit h DNCB through PUV A-exposed skin had 
no effect on subsequent sensitization to a nother hapten, oxa-
solon. T hus, the unresponsiveness induced in Group PUVA-1 
was specific to DNCB used in the ini t ial treatment. 
Reversal of Unresponsiveness by Cyclophosphamide 
Three days before sensitization, cyclophosphamide was in-
jected intra peritoneally at a dose of 200 mg/kg. The guinea pigs 
in Group CY, PUVA-1-CY, and PUVA-2-CY were sensitized to 
DNCB with or without PUV A treatment by procedures similar 
to those done in the control group, Group PUVA-l, and PUVA-
2, respectively, with the exception of cyclophospha mide admin-
istration . In Group CY, cyclophosphamide was given 3 days 
before the sensitization procedure. In Group PUVA-I-CY, cy-
clophosphamide was administered immediately after PUV A 
t reatment and sensit ization was attempted 3 days late r. In 
Group PUVA-2-CY, sensitiz;ltion was first attempted through 
PUV A-treated skin, a nd 8 days later cyclophospha mide was 
injected, and then, the attempt at DNCB sensit ization was done 
at a non treated site 3 days after the cyclophospha mide admin-
istration. 
Such treatment with cyclophosphamide shortly before sen-
sitization markedly enha nced t he degree of cha Uenge reactions 
to DNCB in sensitized guinea pigs a nd reversed the unrespon-
siveness in tolerant a nimals (Table IV). All guinea pigs reacted 
strongly to the challenge with 0.05% DNCB and most of them 
responded well even to a 0.025% solution. 
DISCUSSION ' 
Our results indicate that attem pts at contact sensit ization 
through PUV A-treated skin elicited only a slight degree of 
sensitivity. In the previous sttldy, we demonstrated that the 
identical t reatment with PUV A markedly reduced t he number 
of ATPase-positive Langerhans cells in the guinea-pig epider-
mis [11] and t hat t his inhibitory effect on challenge reac tion 
was long-lasting [12]. Psoralen alone a nd UV A alone did not 
reveal such a n effect in gu inea pigs, although Lynch, Gurish, 
and Daynes [13] fo und that repeated exposures of UVA even 
without 8-MOP had a suppressive effect on the induction of 
contact hypersensitivi ty in mice. The suppressive effect of high 
doses of UV A observed by these authors may be due to the 
minimal UVB radiation emitted by their UV A bulbs. 
Recently Langerhans cells have been implicated as playing 
an important role as antigen-presenting cells in the induction 
of immune reactions to antigens applied through the skin . 
Toews et al [4] have shown a direct correlation between t he 
number of ATPase-positive Langerhans cells and the a bility to 
induce contact hypersensitivity, while contradictory resu lts 
were reported by Lynch et al [13]. Furthermore, Toews et. a l 
observed that a high degree of ant igeh-specific unresponsive-
ness was induced when an tigen was presented through tail skin 
or UVB-exposed body wall skin that was deficient in Langer-
hans cells. The mecha nisms by which PUV A exerts its inhibi-
tory effect on cell-mediated immunity seem to be variable 
depending on the sensitizing procedure and on the s ite and 
extent of PUVA treatments. Meyer, Grundmann, and Weiss 
sensitized t he animals by injecting dinitrofluorobenzene in 
Freund's complete adjuvant into an unirradiated s ite [14]. 
Therefore, t hey excluded an effect of PUV A on La ngerhans 
cells or macrophages in the induction phase. Briffa et al a lso 
used the same sensitizing procedure with ovalbumin as an 
antigen a nd repeatedly exposed the a nimals to PUVA [15]. 
They performed skin testing by in tradermal injection of the 
antigen in to non irradiated skin. These authors suggested the 
possible influence of PUVA on lymphocytes circulating in der-
mal vessels. On the contrary, Morison et al found t hat the site 
of eli citation of a llergy had to be included in the area exposed 
to PUVA in order to demonstrate inhibition of contact sensitiv-
ity reactions to DNCB [16]. Later, Morison et al [17] observed 
a suppression of the cutaneous delayed hypersensit ivi ty reac-
t ion on both t he exposed area and a n adjacent nonirradiated 
area. In this experiment, guinea pigs were immunized by injec-
tion of dinitrophenyl-bovine gamma-globulin in incomplete 
Freund's adj uva nt, and hypersensitivi ty responses were pro-
voked by intradermal injection of antigens. In all investigations 
quoted above, experimental animals were repeatedly exposed 
to PUV A during a relatively long period using unfiltered UV A. 
Our previous experiments also indicated that multiple expo-
sures in a large area were needed to suppress the challenge 
reactions, when induction of contact sensit ization was at-
tempted t hrough non treated skin [12] . In this case, we assumed 
that the suppressive effect of PUV A on contact hypersensitivi ty 
was closely related to the presence of primary phototoxic der-
matitis due to PUV A. On the other ha nd, when PUV A was 
given at'the induction site, only one treatm ent by topical PUV A 
in a small area was enough to suppress challenge reactions, and 
th e effect was long-lasting. This seemed to be caused by im-
pairment of the antigen-presenting function of Langerhans ceU. 
We observed no effect of unftltered UVA radiation on Langer-
hans cell s, when irradiated without 8-methoxypsoralen. There-
fore, the influence of contaminating UVB seemed to be minimal. 
The data presented here indicate that the animals that had 
been first exposed to DNCB through PUVA-treated skin failed 
to become sensitized to the subsequent sensit ization regimen of 
the same hapten even through previously untreated skin . The 
unresponsiveness in these animals was antigen-specific, since 
their capacity to become sensitized to an umelated hapten, 
oxasolon, was not impaired. These findings are quite similaJ' to 
those observed by Toews et al in UVB-irradiated mice [4]. 
Therefore, it seems very likely that PUV A treatment exerts a 
similar influence to UVB-exposure on Langerhans cell function 
and on contact sensitization. 
The induction of a spec ific immunologic unresponsiveness 
has been achieved by various application routes of to lerogens. 
Among them, intravenous injection of less toxic tolerogen a nd 
dinitrobenzene sulfonic acid sodium salt have provided much 
important information about the mechanisms of this phenom-
enon . Using this substance, a complete a nd permanent tolerance 
could be ach ieved regarding con tact sensitivity to DNCB 
[18,19]' In the past few years, evidence has been accumulated 
that specific immunologic unresponsiveness to contact sensiti-
zation with haptens is a positive phenomenon mediated by 
suppressor cells. It has also been shown that suppressor cells 
can be eliminated by the administration of a high dose of 
cyclophosphamide, and that such treatments shortly before 
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immunization markedly enhance the degree of contact sensitiv-
ity in sensitized animals a nd reverse tolerance in unl'esponsive 
animals [20-22]. 
In the present study, we observed that the unl'esponsiveness 
obtained by topical application of DNCB on PUV A-treated 
skin was also reversed by intraperitoneal administration of 
cyclophosphamide. Consequently it can be assumed that the 
tolerance in t hese animals is also a specific immunologic unre-
sponsiveness media ted by suppressor cells. Recently we con-
firm ed in mice tha t the unresponsiveness can be transferred to 
syngeneic recipients using spleen cells and that the suppression 
by spleen cells was a brogated by antibody to T cell-specific 
antigen (Thy 1.2) and complement treatm ent (unpublished 
data) . 
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Activation of Complement by Pityrosporum orbiculare 
PETER G. SOHNLE, M.D. AND CATHLEEN COLLINS-LECH, B.A. 
Section of In.fectious Diseases, Department of M edicine, The M edical Co llege of Wiscons,:n, Milwaukee, and the Medical and R esearch 
Services, Veterans Administration M edical Centel ~ Wood (Milwauhee), Wisconsin, U.S.A. 
The ability to activate complement in human serum 
was evaluated for the two yeast-like urganisms Pityros-
porum orbiculare, the presumed etiologic agent of tinea 
versicolor, and Candida albicans. Complement activa-
tion was measured by: (a) using inhibition of rabbit red 
blood cell lysis by human serum after incubation with 
the organisms, and (b) quantitation of the amount of C3 
deposited on the surface of the yeast by an enzyme-
linked immunoabsorbent assay. It was found that both 
organisms had approximately equal ability to activate 
complement in normal serum or serum having only the 
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alternative pathway intact, even though extracts of C. 
albicans contained significantly greater amounts of both 
carbohydrate and antigenic material capable of combin-
ing with the antibody present in normal human serum. 
The marked difference in inflammation in the cutaneous 
lesions produced by these two organisms does not ap-
pear to be related to their complement-activating ability 
and is more likely due to some other factor such as 
differences in invasiveness or in ability to elicit other 
immunologic reactions. 
Veterans Administration Medical Center, Woorl , Wisconsin 53193. 
Abbreviations: 
EGTA: ethylene glycol-bis-( beta-amino ethyl ether)-N ,N'- t.etra-
acetic acid 
ELISA: enzyme-linked immul1oabsorbent assay 
PBS: phosphate-buffered saline 
RBC: red-blood cells 
